[1]
Mikael Bjursell et al. 2025. Therapeutic CRISPR/Cas9 Genome Editing in a Humanized Mouse Model Ameliorates \(\alpha\)1-antitrypsin Deficiency Phenotype. Research Perspectives of Microbiology and Biotechnology Vol. 9. (Jan. 2025), 14–31. DOI:https://doi.org/10.9734/bpi/rpmab/v9/3611.